Soluble Urokinase-Type Plasminogen Activator Receptor Improves Risk Prediction in Patients With Chronic Heart Failure.

Koller, Lorenz

Soluble Urokinase-Type Plasminogen Activator Receptor Improves Risk Prediction in Patients With Chronic Heart Failure. [electronic resource] - JACC. Heart failure 04 2017 - 268-277 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

2213-1787

10.1016/j.jchf.2016.12.008 doi


Aged
Cardiovascular Diseases--mortality
Cause of Death
Chronic Disease
Cohort Studies
Female
Heart Failure--blood
Humans
Male
Middle Aged
Mortality
Predictive Value of Tests
Prognosis
Proportional Hazards Models
Receptors, Urokinase Plasminogen Activator--blood
Reproducibility of Results
Risk Assessment